A Practical Approach to the Detection of Prognostically Significant Genomic Aberrations in Multiple Myeloma
Authors:
- Zhong ChenZCZhong Chen
- Bonnie IssaBIBonnie Issa
- Shiang HuangSHShiang Huang
- Emily AstonEAEmily Aston
- Jia XuJXJia Xu
- Margaret YuMYMargaret Yu
- Arthur R. BrothmanABArthur R. Brothman
- Martha GlennMGMartha Glenn
- 1 November 2005
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 7 (5) , 560-565
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Flow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple MyelomaAmerican Journal of Clinical Pathology, 2004
- Flow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple MyelomaAmerican Journal of Clinical Pathology, 2004
- Genetics and Cytogenetics of Multiple MyelomaCancer Research, 2004
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myelomaLeukemia, 2003
- Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapyBlood, 2001
- PHA/IL2: An Efficient Mitogen Cocktail for Cytogenetic Studies of Non-Hodgkin Lymphoma and Chronic Lymphocytic LeukemiaCancer Genetics and Cytogenetics, 1999
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- MULTIPLE MYELOMA: ALMOST ALL PATIENTS ARE CYTOGENETICALLY ABNORMALBritish Journal of Haematology, 1996
- Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate ProteoglycansAnnual Review of Cell Biology, 1992